Anna Orlova
Uppsala Universitet
H-index: 59
Europe-Sweden
Top articles of Anna Orlova
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors | Molecular Pharmaceutics | Maria Larkina Ruslan Varvashenya Feruza Yuldasheva Evgenii Plotnikov Ekaterina Bezverkhniaia | 2024/4/1 |
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation | EJNMMI Radiopharmacy and Chemistry | Maryam Oroujeni Matilda Carlqvist Eva Ryer Anna Orlova Vladimir Tolmachev | 2024/4/16 |
Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m | International Journal of Molecular Sciences | Ekaterina Bezverkhniaia Panagiotis Kanellopoulos Ulrika Rosenström Vladimir Tolmachev Anna Orlova | 2024/3/23 |
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia | Journal of Clinical Investigation | Tobias Suske Helena Sorger Gabriele Manhart Frank Ruge Nicole Prutsch | 2024/4/15 |
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology | EJNMMI Radiopharmacy and Chemistry | Panagiotis Kanellopoulos Adam Mattsson Ayman Abouzayed Karim Obeid Berthold A Nock | 2024/2/16 |
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion | International Journal of Molecular Sciences | Sergey M Deyev Maryam Oroujeni Javad Garousi Torbjörn Gräslund Ruonan Li | 2024/4/11 |
Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography … | ACS omega | Panagiotis Kanellopoulos Ekaterina Bezverkhniaia Ayman Abouzayed Ulrika Rosenström Vladimir Tolmachev | 2024/4/10 |
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics | Pharmaceutics | Karim Obeid Panagiotis Kanellopoulos Ayman Abouzayed Adam Mattsson Vladimir Tolmachev | 2024/4/8 |
Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting | ACS Pharmacology & Translational Science | Kristina Westerlund Maryam Oroujeni Maxime Gestin Jacob Clinton Alia Hani Rosly | 2024/4/29 |
Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs | Journal of Controlled Release | Wen Yin Tianqi Xu Haozhong Ding Jie Zhang Vitalina Bodenko | 2023/3/1 |
Check for updates Chapter 11 | SH2 Domains: Functional Modules and Evolving Tools in Biology | Elvin D de Araujo Anna Orlova Qirat F Ashraf Richard Moriggl Patrick T Gunning | 2023/9/5 |
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity | Diagnostics | Ayman Abouzayed Jesper Borin Fanny Lundmark Anastasiya Rybina Sophia Hober | 2023/5/2 |
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry | Frontiers in Oncology | Ayman Abouzayed Kamila Seitova Fanny Lundmark Vitalina Bodenko Maryam Oroujeni | 2023 |
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model | International Journal of Molecular Sciences | Tianqi Xu Alexey Schulga Elena Konovalova Sara S Rinne Hongchao Zhang | 2023/2/2 |
Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity | Journal of Controlled Release | Charles Dahlsson Leitao Anna Mestre Borras Tianqi Xu Maryam Oroujeni Yongsheng Liu | 2023/5/1 |
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3 | Nuclear Medicine and Biology | Maryam Oroujeni Ekaterina A Bezverkhniaia Tianqi Xu Yongsheng Liu Evgenii V Plotnikov | 2023/9/1 |
A Comparison of in vivo Half-life Extension of Affibody-Drug Conjugates by PASylation, XTENylation and Albumin Binding | Jie Zhang Vitalina Bodenko Maria Larkina Yekaterina Bezverkhnyaya Tianqi Xu | 2023 | |
Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical … | Cancers | Fanny Lundmark Ayman Abouzayed Sara S Rinne Vasiliy Timofeev Nadezhda Sipkina | 2023/1/10 |
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab | Cancers | Yongsheng Liu Tianqi Xu Anzhelika Vorobyeva Annika Loftenius Vitalina Bodenko | 2023/4/22 |
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway | Molecular Cancer | Jan Pencik Cecile Philippe Michaela Schlederer Emine Atas Matteo Pecoraro | 2023/8/12 |
